NASDAQ:ATOS   Atossa Therapeutics, Inc.
ATOS

* All the data is in chart,

TP1 ~ 2.55
TP2 ~2.75
Comment:
Before July 100% Profit
Comment:
I smell buy out or merge, consolidating at this level , and 50m $ Direct offering exactly before P2 FDA results.
a huge uptrend possibility here

no pain, no gain
Unveiling illusions, revealing wealth
Disclaimer

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.